BioLineRx Ltd (BLRX)

[BarrellofHay]

From the earnings call "....end users of APHEXDA transplant centers are well defined with approximately 80 of 212 transplant centers performing the vast majority approximately 85% of all procedures. Among this defined population, we have already secured formulary placement within these top 80 transplant centers managing approximately 20% of all stem cell transplant procedures at these institutions." and "and we anticipate that by year-end we will have secured formulary placement within these top 80 transplant centers managing approximately 60% of all stem cell transplant procedures."
From Investor report "~ 8,000 ASCTs in USA alone"
Translation math (assuming $10,000 per ASCTs -correct me if i am wrong on amount):
Now: $10,000x8,000x0.85x0.2= $13.6 million in yearly revenue equivalent NOW
End of year: $10,000x8,000x0.85x0.6 = $40.8 million